Arrowhead Pharmaceuticals (ARWR)
(Delayed Data from NSDQ)
$21.34 USD
+0.77 (3.74%)
Updated Nov 6, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Earnings Date | *AMC11/26/24 |
---|---|
Current Quarter | -0.63 |
EPS Last Quarter | -1.38 |
Last EPS Surprise | -137.93% |
ABR | 1.73 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.31 |
Next Year | -3.80 |
EPS (TTM) | -4.67 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 115.50M | 34.70M | 96.32M | 219.23M |
# of Estimates | 5 | 1 | 8 | 7 |
High Estimate | 250.00M | 34.70M | 253.60M | 442.70M |
Low Estimate | 19.20M | 34.70M | 3.55M | 20.00M |
Year ago Sales | 16.10M | 3.55M | 240.74M | 96.32M |
Year over Year Growth Est. | 617.39% | 877.46% | -59.99% | 127.61% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.63 | -1.23 | -4.31 | -3.80 |
# of Estimates | 9 | 2 | 11 | 10 |
Most Recent Consensus | -0.47 | NA | -4.78 | -1.76 |
High Estimate | 0.54 | -0.92 | -3.04 | -1.76 |
Low Estimate | -1.49 | -1.54 | -5.12 | -6.29 |
Year ago EPS | -1.03 | -1.24 | -1.92 | -4.31 |
Year over Year Growth Est. | 38.83% | 0.81% | -124.48% | 11.87% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Current | -0.63 | -1.23 | -4.31 | -3.80 |
7 Days Ago | -0.63 | -1.23 | -4.31 | -3.80 |
30 Days Ago | -0.63 | -1.23 | -4.31 | -3.80 |
60 Days Ago | -0.63 | -1.23 | -4.31 | -3.80 |
90 Days Ago | -0.58 | -1.12 | -3.68 | -3.51 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.63 | -1.23 | -4.31 | -3.80 |
Zacks Consensus Estimate | -0.63 | -1.23 | -4.31 | -3.80 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.38 | -1.02 | -1.24 | -1.03 | NA |
Estimate | -0.58 | -0.06 | -0.78 | -0.70 | NA |
Difference | -0.80 | -0.96 | -0.46 | -0.33 | -0.64 |
Surprise | -137.93% | -1,600.00% | -58.97% | -47.14% | -461.01% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more